PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors-中国期刊网

摘要 Cancerevadeshostimmunesurveillancebyusingimmunecheckpoints,whichareinhibitorypathwayscrucialformaintainingself-tolerance1.Tumorcellsexpressmultipleinhibitoryligands,andtumor-infiltratinglymphocytes(TIL)expressavarietyofinhibitoryreceptors.InhibitoryreceptorscytotoxicT-lymphocyte-associatedprotein4(CTLA-4)andprogrammeddeath-1

1Yuchen Bai;Xiaoxia Chen;Likun Hou;Jun Qian;Tao Jiang;Caicun Zhou;Maciej Ciebiada. PD-L1 expression and its effect on clinical outcomes of EGFRmutant NSCLC patients treated with EGFR-TKIs.肿瘤,2018-04.
2Dylan A. Levy,Jaimin J. Patel,Shaun A. Nguyen,W. Nicholas Jungbauer,David M. Neskey,Ezra E. W. Cohen,Chrystal M. Paulos,John A. Kaczmar,Hannah M. Knochelmann,Terry A. Day. Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis.医药卫生,2022-12.
3李姝萍,王小珏,杨斌,王和林,闫卓红,易玲,韦攀健,金鑫,郝建清,张洪涛. EGFR和PD-L1双靶向嵌合抗原受体构建及表达.医药卫生,2020-08.
4张兴博李楠. PD-1/PD-L1抑制剂研究进展.临床医学,2019-06.
5骆飞;孙昭;白春梅. PD-1/PD-L1在胃癌中的研究进展.肿瘤,2016-06.
6郭又嘉，雷宇通讯作者. PD-1/PD-L1免疫疗法药物的研究进展.临床医学,2017-11.
7陈志静1杨姣2（通讯作者）. PD-L1在肿瘤免疫逃逸的作用.公共卫生与预防医学,2016-06.
8Long Jia;Qi Zhang;Rongxin Zhang. PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy.肿瘤,2018-02.
9乐炜. PD-1/PD-L1在鼻咽癌的研究进展.临床医学,2018-04.
10杨苏彬,许凤燕. PD-1/PD-L1及其与免疫相关疾病的研究进展.医药卫生,2020-08.

PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors

来源期刊

相关推荐

同分类资源更多

相关关键词

PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors

来源期刊

相关推荐

同分类资源 更多

相关关键词

同分类资源更多